ID   CYTB_HUMAN              Reviewed;          98 AA.
AC   P04080;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   22-APR-2020, entry version 215.
DE   RecName: Full=Cystatin-B;
DE   AltName: Full=CPI-B;
DE   AltName: Full=Liver thiol proteinase inhibitor;
DE   AltName: Full=Stefin-B;
GN   Name=CSTB; Synonyms=CST6, STFB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PROTEIN SEQUENCE.
RX   PubMed=3902020; DOI=10.1016/0006-291x(85)90216-5;
RA   Ritonja A., Machleidt W., Barrett A.J.;
RT   "Amino acid sequence of the intracellular cysteine proteinase inhibitor
RT   cystatin B from human liver.";
RL   Biochem. Biophys. Res. Commun. 131:1187-1192(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8596935; DOI=10.1126/science.271.5256.1731;
RA   Pennacchio L.A., Lehesjoki A.-E., Stone N.E., Willour V.L., Virteneva K.,
RA   Miao J., D'Amato E., Ramirez L., Faham J., Koskiniemi M., Warringtion J.A.,
RA   Norio R., la Chapelle A., Cox D.R., Myers R.M.;
RT   "Mutations in the gene encoding cystatin B in progressive myoclonus
RT   epilepsy (EPM1).";
RL   Science 271:1731-1734(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bhat K.S.;
RL   Submitted (MAY-1993) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11139332; DOI=10.1006/excr.2000.5085;
RA   Riccio M., Di Giaimo R., Pianetti S., Palmieri P.P., Melli M., Santi S.;
RT   "Nuclear localization of cystatin B, the cathepsin inhibitor implicated in
RT   myoclonus epilepsy (EPM1).";
RL   Exp. Cell Res. 262:84-94(2001).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=2347312; DOI=10.1002/j.1460-2075.1990.tb08321.x;
RA   Stubbs M.T., Laber B., Bode W., Huber R., Jerala R., Lenarcic B., Turk V.;
RT   "The refined 2.4 A X-ray crystal structure of recombinant human stefin B in
RT   complex with the cysteine proteinase papain: a novel type of proteinase
RT   inhibitor interaction.";
RL   EMBO J. 9:1939-1947(1990).
RN   [13]
RP   VARIANT EPM1 ARG-4.
RX   PubMed=9012407;
RA   Lalioti M.D., Mirotsou M., Buresi C., Peitsch M.C., Rossier C.,
RA   Ouazzani R., Baldy-Moulinier M., Bottani A., Malafosse A.,
RA   Antonarakis S.E.;
RT   "Identification of mutations in cystatin B, the gene responsible for the
RT   Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).";
RL   Am. J. Hum. Genet. 60:342-351(1997).
CC   -!- FUNCTION: This is an intracellular thiol proteinase inhibitor. Tightly
CC       binding reversible inhibitor of cathepsins L, H and B.
CC   -!- SUBUNIT: Able to form dimers stabilized by noncovalent forces.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11139332}. Nucleus
CC       {ECO:0000269|PubMed:11139332}.
CC   -!- DISEASE: Epilepsy, progressive myoclonic 1 (EPM1) [MIM:254800]: An
CC       autosomal recessive disorder characterized by severe, stimulus-
CC       sensitive myoclonus and tonic-clonic seizures. The onset, occurring
CC       between 6 and 13 years of age, is characterized by convulsions.
CC       Myoclonus begins 1 to 5 years later. The twitchings occur predominantly
CC       in the proximal muscles of the extremities and are bilaterally
CC       symmetrical, although asynchronous. At first small, they become late in
CC       the clinical course so violent that the victim is thrown to the floor.
CC       Mental deterioration and eventually dementia develop.
CC       {ECO:0000269|PubMed:9012407}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cystatin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CSTBID40181ch21q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U46692; AAA99014.1; -; Genomic_DNA.
DR   EMBL; L03558; AAA35727.1; -; mRNA.
DR   EMBL; AF208234; AAF44059.1; -; Genomic_DNA.
DR   EMBL; AP001752; BAA95541.1; -; Genomic_DNA.
DR   EMBL; BC003370; AAH03370.1; -; mRNA.
DR   EMBL; BC010532; AAH10532.1; -; mRNA.
DR   CCDS; CCDS13701.1; -.
DR   PIR; A01278; UDHUB.
DR   RefSeq; NP_000091.1; NM_000100.3.
DR   PDB; 1STF; X-ray; 2.37 A; I=1-98.
DR   PDB; 2OCT; X-ray; 1.40 A; A/B=1-98.
DR   PDB; 4N6V; X-ray; 1.80 A; 0/1/2/3/4/5/6/7/8/9=8-98.
DR   PDBsum; 1STF; -.
DR   PDBsum; 2OCT; -.
DR   PDBsum; 4N6V; -.
DR   SMR; P04080; -.
DR   BioGrid; 107858; 32.
DR   IntAct; P04080; 12.
DR   MINT; P04080; -.
DR   STRING; 9606.ENSP00000291568; -.
DR   DrugBank; DB09131; Cupric Chloride.
DR   MEROPS; I25.003; -.
DR   TCDB; 1.C.91.1.1; the stefin b pore-forming protein (stefin b) family.
DR   iPTMnet; P04080; -.
DR   PhosphoSitePlus; P04080; -.
DR   SwissPalm; P04080; -.
DR   BioMuta; CSTB; -.
DR   DMDM; 1706278; -.
DR   CPTAC; CPTAC-184; -.
DR   CPTAC; CPTAC-185; -.
DR   EPD; P04080; -.
DR   jPOST; P04080; -.
DR   MassIVE; P04080; -.
DR   PaxDb; P04080; -.
DR   PeptideAtlas; P04080; -.
DR   PRIDE; P04080; -.
DR   ProteomicsDB; 51648; -.
DR   TopDownProteomics; P04080; -.
DR   Antibodypedia; 4378; 759 antibodies.
DR   DNASU; 1476; -.
DR   Ensembl; ENST00000291568; ENSP00000291568; ENSG00000160213.
DR   GeneID; 1476; -.
DR   KEGG; hsa:1476; -.
DR   CTD; 1476; -.
DR   DisGeNET; 1476; -.
DR   GeneCards; CSTB; -.
DR   GeneReviews; CSTB; -.
DR   HGNC; HGNC:2482; CSTB.
DR   HPA; ENSG00000160213; Tissue enhanced (esophagus, lymphoid tissue, tongue).
DR   MalaCards; CSTB; -.
DR   MIM; 254800; phenotype.
DR   MIM; 601145; gene.
DR   neXtProt; NX_P04080; -.
DR   OpenTargets; ENSG00000160213; -.
DR   Orphanet; 308; Unverricht-Lundborg disease.
DR   PharmGKB; PA26984; -.
DR   eggNOG; ENOG410IZK7; Eukaryota.
DR   eggNOG; ENOG41121QW; LUCA.
DR   GeneTree; ENSGT00940000154826; -.
DR   HOGENOM; CLU_150234_2_0_1; -.
DR   InParanoid; P04080; -.
DR   KO; K13907; -.
DR   OMA; SLPHEDK; -.
DR   OrthoDB; 1647595at2759; -.
DR   PhylomeDB; P04080; -.
DR   TreeFam; TF333174; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; CSTB; human.
DR   EvolutionaryTrace; P04080; -.
DR   GeneWiki; Cystatin_B; -.
DR   GenomeRNAi; 1476; -.
DR   Pharos; P04080; Tbio.
DR   PRO; PR:P04080; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; P04080; protein.
DR   Bgee; ENSG00000160213; Expressed in mouth mucosa and 237 other tissues.
DR   ExpressionAtlas; P04080; baseline and differential.
DR   Genevisible; P04080; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0004866; F:endopeptidase inhibitor activity; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IDA:MGI.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0010466; P:negative regulation of peptidase activity; IDA:BHF-UCL.
DR   GO; GO:0045861; P:negative regulation of proteolysis; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   CDD; cd00042; CY; 1.
DR   InterPro; IPR000010; Cystatin_dom.
DR   InterPro; IPR018073; Prot_inh_cystat_CS.
DR   InterPro; IPR001713; Prot_inh_stefin.
DR   PANTHER; PTHR11414; PTHR11414; 1.
DR   Pfam; PF00031; Cystatin; 1.
DR   PRINTS; PR00295; STEFINA.
DR   SMART; SM00043; CY; 1.
DR   PROSITE; PS00287; CYSTATIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Epilepsy; Nucleus; Protease inhibitor;
KW   Reference proteome; Thiol protease inhibitor.
FT   CHAIN           1..98
FT                   /note="Cystatin-B"
FT                   /id="PRO_0000207136"
FT   MOTIF           46..50
FT                   /note="Secondary area of contact"
FT   SITE            4
FT                   /note="Reactive site"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895"
FT   VARIANT         4
FT                   /note="G -> R (in EPM1; dbSNP:rs74315443)"
FT                   /evidence="ECO:0000269|PubMed:9012407"
FT                   /id="VAR_002206"
FT   CONFLICT        31
FT                   /note="E -> Y (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           14..31
FT                   /evidence="ECO:0000244|PDB:2OCT"
FT   STRAND          39..58
FT                   /evidence="ECO:0000244|PDB:2OCT"
FT   STRAND          60..62
FT                   /evidence="ECO:0000244|PDB:1STF"
FT   STRAND          64..74
FT                   /evidence="ECO:0000244|PDB:2OCT"
FT   STRAND          80..89
FT                   /evidence="ECO:0000244|PDB:2OCT"
SQ   SEQUENCE   98 AA;  11140 MW;  B8076220E19D0483 CRC64;
     MMCGAPSATQ PATAETQHIA DQVRSQLEEK ENKKFPVFKA VSFKSQVVAG TNYFIKVHVG
     DEDFVHLRVF QSLPHENKPL TLSNYQTNKA KHDELTYF
//
